Literature DB >> 18366977

Adrenal-preserving minimally invasive surgery: update on the current status of laparoscopic partial adrenalectomy.

Grant I S Disick1, Ravi Munver.   

Abstract

Adrenalectomy is the standard of care for hormonally active adrenal masses. In recent years, minimally invasive laparoscopic excision has become a preferred management option. As with advances in parenchymal-sparing renal surgery, investigators have begun to examine adrenal-sparing procedures to preserve functional adrenal tissue. This article reviews the recent literature and reports on intermediate results with laparoscopic partial adrenalectomy (LPA).

Mesh:

Year:  2008        PMID: 18366977     DOI: 10.1007/s11934-008-0013-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  42 in total

1.  Partial laparoscopic adrenalectomy for aldosterone-producing adenoma: short-and long-term results.

Authors:  S Al-Sobhi; R Peschel; G Bartsch; R Gasser; G Finkenstedt; G Janetschek
Journal:  J Endourol       Date:  2000-08       Impact factor: 2.942

Review 2.  Minimal access adrenal surgery.

Authors:  L M Brunt
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

Review 3.  Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas.

Authors:  N W Thompson; P S Cheung
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

4.  Unilateral laparoscopic adrenalectomy followed by contralateral retroperitoneoscopic partial adrenalectomy in a patient with multiple endocrine neoplasia type 2a syndrome.

Authors:  S Mugiya; K Suzuki; K Saisu; K Fujita
Journal:  J Endourol       Date:  1999-03       Impact factor: 2.942

5.  Laparoscopic adrenalectomy: a new standard of care.

Authors:  H I Vargas; L R Kavoussi; D L Bartlett; J R Wagner; D J Venzon; D L Fraker; H R Alexander; W M Linehan; M M Walther
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

Review 6.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

7.  Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias.

Authors:  Martin K Walz; Klaus Peitgen; Daniela Diesing; Stephan Petersenn; Onno E Janssen; Thomas Philipp; Klaus A Metz; Klaus Mann; Kurt W Schmid; Hartmut P H Neumann
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

8.  Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy.

Authors:  Michael Brauckhoff; Oliver Gimm; Phuong Nguyen Thanh; Annett Bär; Jörg Ukkat; Katrin Brauckhoff; Thomas Bönsch; Henning Dralle
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

9.  Retroperitoneoscopic partial adrenalectomy using an endoscopic stapling device in patients with adrenal tumor.

Authors:  I Sasagawa; H Suzuki; T Tateno; T Izumi; N Shoji; T Nakada
Journal:  Urol Int       Date:  1998       Impact factor: 2.089

10.  Adrenal autografts following bilateral adrenalectomy.

Authors:  A M Lucon; B B Mendonça; S Domenice; J L Chambô; B L Wajchemberg; S Arap
Journal:  J Urol       Date:  1993-05       Impact factor: 7.450

View more
  3 in total

Review 1.  Diagnosis and treatment of the adrenal cyst.

Authors:  Alexei Wedmid; Michael Palese
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

Review 2.  Surgical, interventional, and device innovations in the management of hypertension.

Authors:  Sibu P Saha; Khaled M Ziada; Thomas F Whayne
Journal:  Int J Angiol       Date:  2015-03

3.  Retroperitoneoscopic partial adrenalectomy for metachronous renal cell carcinoma metastasis to solitary adrenal gland.

Authors:  Go Kaneko; Masahiro Katsui; Hideki Orikasa; Seiya Hattori; Satoshi Hara
Journal:  Int Cancer Conf J       Date:  2019-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.